Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ajinomoto Co. Inc.
DescriptionGranule formulation of branched-chain amino acid (isoleucine, leucine and valine)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Hepatic (unspecified)
Indication DetailsTreat hypoalbuminemia in patients with decompensated liver cirrhosis
Regulatory Designation
PartnerEisai Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today